V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300006939 | 300005008 | 1.77 | 74.7 | Not known (9) | 2016-03-20 | 2016-03-26 | Cisplatin 7 day | 02 | null | 300024933 | CISPLATIN + FLUOROURACIL |
| 300006940 | 300005009 | 1.79 | null | Disease modification (D) | 2014-10-17 | 2014-11-15 | DAIICHI Trial | N | N | 300024942 | CETUXIMAB + RT |
| 300006941 | 300005010 | 1.77 | 88.3 | Palliative (P) | 2014-01-02 | 2014-12-08 | PEMBROLIZUMAB | 02 | N | 300024942 | DOCETAXEL |
| 300006942 | 300005011 | 1.56 | 68.3 | Curative (C) | 2016-06-21 | 2016-06-21 | TOTEM TRIAL | N | N | 300024966 | DOCETAXEL |
| 300006943 | 300005012 | 1.9 | null | Palliative (P) | 2017-07-14 | 2017-08-13 | CARBOPLATIN + Cetuximab + FLUOROURACIL | null | null | 300024966 | CVD |
| 300006946 | 300005015 | 1.81 | 84.6 | Palliative (P) | null | 2016-12-30 | DE-ESCALATE TRIAL | N | null | 300025008 | ESPAC TRIAL |
| 300006947 | 300005015 | 1.53 | 52.6 | Curative (C) | 2015-06-19 | 2015-06-20 | CARBOPLATIN + CETUXIMAB + FU | N | Y | 300025008 | CETUXIMAB + RT |
| 300006948 | 300007839 | 1.76 | 90.4 | Curative (C) | 2018-01-05 | 2018-02-01 | ESPAC-4 TRIAL | Y | null | 300025042 | TRIAL |
| 300006949 | 300005017 | 1.46 | 58.9 | Palliative (P) | 2015-10-05 | 2015-10-05 | Trial Unspecified | N | null | 300025053 | CISPLATIN + FLUOROURACIL |
| 300006952 | 300005018 | 1.84 | 78.3 | Curative (C) | 2015-09-30 | 2015-10-26 | Cisplatin 7 day | Y | null | 300025082 | DE-ESCALATE TRIAL |
| 300006953 | 300007087 | 1.82 | 54 | Palliative (P) | 2014-02-25 | 2014-03-10 | EOX | N | N | 300025085 | OXALIPLATIN + MDG |
| 300006954 | 300005020 | null | 81.4 | Adjuvant (A) | null | 2016-10-28 | Paclitaxel 7 day | null | null | 300025088 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300006955 | 300005021 | 1.67 | 54 | Adjuvant (A) | null | 2014-07-05 | Cetuximab + Radiotherapy Maint | 02 | Y | 300025105 | GEMCITABINE + RT |
| 300006957 | 300005023 | null | 72 | Adjuvant (A) | 2015-11-14 | 2015-12-07 | FEC 100 | null | null | 300025156 | TRIAL |
| 300006958 | 300005023 | 1.62 | 104.6 | Adjuvant (A) | null | 2013-02-27 | Cisplatin 7 day | null | null | 300025156 | CISPLATIN |
| 300006959 | 300005024 | 1.67 | 82.9 | Palliative (P) | 2013-10-26 | 2013-11-15 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300025182 | CAPECITABINE + GEMCITABINE |
| 300006960 | 300005024 | 1.6 | 54.3 | Adjuvant (A) | 2014-07-23 | 2014-07-24 | Irinotecan + Modified De Gramont | N | N | 300025182 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300006961 | 300005025 | 1.74 | 118.3 | Palliative (P) | 2014-08-17 | 2014-09-06 | Cetuximab 7 day (>Cycle 2) | N | N | 300025196 | PACLITAXEL |
| 300006962 | 300005026 | 1.46 | 74.8 | Curative (C) | 2016-03-12 | 2016-03-25 | CETUXIMAB + RT | 02 | Y | 300025197 | CAPECITABINE + RT |
| 300006963 | 300005027 | null | 64.9 | Curative (C) | 2015-02-07 | 2015-02-07 | Cetuximab 7 day (>Cycle 2) | 02 | Y | 300025205 | CARBOPLATIN |
| 300006964 | 300005028 | 1.81 | 51.8 | Palliative (P) | 2017-03-19 | 2017-05-05 | ESPAC-4 TRIAL | N | null | 300025221 | CAPECITABINE |
| 300006965 | 300005029 | 1.58 | 82 | Palliative (P) | 2017-06-30 | 2017-07-13 | CAPECITABINE + OXALIPLATIN | Y | N | 300025221 | CETUXIMAB + CISPLATIN + FU |
| 300006968 | 300005035 | 1.59 | null | Curative (C) | 2017-01-13 | 2017-02-09 | Cetuximab 7 day (>Cycle 2) | N | Y | 300025258 | CETUXIMAB |
| 300006972 | 300005039 | 1.6 | 102.5 | Curative (C) | 2016-11-21 | 2016-11-22 | CARBOPLATIN + RT | N | Y | 300025311 | CARBOPLATIN |
| 300006973 | 300005040 | null | 68.9 | Adjuvant (A) | 2016-08-07 | 2016-08-18 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 02 | N | 300025313 | TRIAL |
| 300006974 | 300005042 | 1.59 | 89 | Palliative (P) | 2017-05-26 | 2017-06-07 | CAPECITABINE + OXALIPLATIN | 2 | N | 300025329 | IPILIMUMAB |
| 300006975 | 300005043 | null | 90 | Palliative (P) | 2014-09-15 | 2014-10-14 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | null | 300025342 | ESPAC TRIAL |
| 300006976 | 300007095 | null | 46.6 | Palliative (P) | 2015-11-10 | 2016-01-03 | Cetuximab + Radiotherapy Maint | N | null | 300025345 | CARBOPLATIN + PACLITAXEL |
| 300006977 | 300007095 | null | null | Neo-adjuvant (N) | 2013-11-23 | 2013-12-03 | Alemtuzumab + Cyclophos TBI Allo | N | Y | 300025345 | CISPLATIN + FLUOROURACIL |
| 300006978 | 300007095 | null | 72.4 | Palliative (P) | 2015-09-23 | 2015-09-30 | PACLITAXEL | N | N | 300025345 | CAPECITABINE + OXALIPLATIN |
| 300006979 | 300007095 | 1.66 | 85.2 | null | 2013-04-18 | 2013-06-02 | MITOMYCIN | N | null | 300025345 | CAPECITABINE |
| 300006982 | 300007844 | 1.56 | 44.6 | Neo-adjuvant (N) | 2017-07-30 | 2017-09-06 | Capecitabine + Oxaliplatin 14day | N | N | 300025403 | CETUXIMAB |
| 300006983 | 300005048 | null | null | Palliative (P) | 2016-05-30 | 2016-06-12 | Carboplatin AUC 2 - 5 | 02 | N | 300025405 | CETUXIMAB |
| 300006984 | 300007845 | null | 78 | Curative (C) | 2014-11-27 | 2014-12-16 | Cetuximab + Radiotherapy Load | N | null | 300025453 | OXALIPLATIN |
| 300006985 | 300005050 | null | 64.8 | null | 2015-04-06 | 2015-04-09 | Cetuximab 7 day (>Cycle 2) | 02 | N | 300025458 | CAPECITABINE + RT |
| 300006986 | 300005056 | 1.76 | 74.5 | null | 2016-02-08 | 2016-02-11 | METROBIBF trial | 02 | null | 300025465 | OXALIPLATIN |
| 300006987 | 300005057 | 1.45 | 52.75 | Palliative (P) | 2016-03-10 | 2016-03-17 | CARBOPLATIN + CETUXIMAB + FU | N | Y | 300025465 | CARBOPLATIN + RT |
| 300006988 | 300005059 | 1.64 | 57 | Palliative (P) | 2014-08-07 | 2014-08-08 | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | N | N | 300025504 | CISPLATIN |
| 300006989 | 300005060 | 1.65 | 75.3 | Palliative (P) | 2016-09-13 | 2018-01-31 | Cetuximab + Radiotherapy Maint | N | Y | 300025539 | CAPECITABINE |
| 300006990 | 300005061 | 1.46 | 48.5 | Palliative (P) | 2016-04-14 | 2016-09-11 | Trial Unspecified | 2 | N | 300025542 | OXALIPLATIN + MDG |
| 300006991 | 300005062 | 1.61 | 95.7 | Neo-adjuvant (N) | 2017-09-02 | 2017-09-03 | CARBOPLATIN + PACLITAXEL | 2 | N | 300025561 | CETUXIMAB + CISPLATIN + FU |
| 300006992 | 300005063 | 1.7 | null | Curative (C) | 2015-02-12 | 2015-04-27 | Capecitabine | 02 | null | 300025574 | FLUOROURACIL |
| 300006993 | 300005064 | 1.6 | 98.8 | Palliative (P) | null | 2016-02-12 | Oxaliplatin + Modified de Gramont | N | N | 300025592 | CISPLATIN + FLUOROURACIL |
| 300006994 | 300005066 | 1.75 | 88.3 | null | 2017-04-23 | 2017-05-11 | Folfirinox | 02 | N | 300025612 | CARBOPLATIN |
| 300006995 | 300005066 | 1.65 | 115.7 | Adjuvant (A) | 2015-01-11 | 2015-01-19 | CISPLATIN + FLUOROURACIL | 02 | N | 300025612 | IRINOTECAN + MDG |
| 300006996 | 300005068 | 1.54 | 81.9 | Disease modification (D) | 2013-04-22 | 2013-04-22 | CARBOPLATIN + RT | 02 | Y | 300025645 | CARBOPLATIN + CETUXIMAB + FU |
| 300006997 | 300005069 | 1.81 | 81.35 | Palliative (P) | 2014-01-17 | 2014-01-18 | CARBOPLATIN + RT | null | Y | 300025651 | CARBOPLATIN + RT |
| 300006998 | 300005070 | null | 60 | Adjuvant (A) | 2018-02-14 | 2018-02-26 | Cetuximab 7 day (>Cycle 2) | N | N | 300025657 | EOX |
| 300006999 | 300005071 | null | 64.2 | Adjuvant (A) | 2016-07-14 | 2016-07-25 | Trial Unspecified | N | N | 300025675 | IRINOTECAN + MDG |
| 300007000 | 300007103 | null | 83.9 | Palliative (P) | 2015-12-14 | 2015-12-28 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 300025695 | CAPECITABINE |